Bristol-Myers Squibb has initiated a voluntary recall of Coumadin (warfarin sodium) crystalline 5mg tablets, which are used to treat or prevent blood clots.

The recall is a precautionary measure based on the company’s testing of tablets from a returned bottle. Around 2.5 million pills are thought to be affected by the recall.

The company is working to ensure patient safety and resolve this issue quickly and appropriately.